跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PLERIXAFOR SEACROSS 20 MG/ML SOLUCION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PLERIXAFOR SEACROSS 20 MG/ML SOLUCION INYECTABLE EFG
Approved
STANDARD
PLERIXAFOR SEACROSS 20 MG/ML SOLUCION INYECTABLE EFG
Seacross Pharma (Europe) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 10, 2023
Approval ID
780f2665726ca292
Company
Seacross Pharma (Europe) Limited
Type
Standard
Approval Details
Approval Id
780f2665726ca292
Drug Cima Aemps Name
PLERIXAFOR SEACROSS 20 MG/ML SOLUCION INYECTABLE EFG
Register Number
88951
Holder Company Name
Seacross Pharma (Europe) Limited
Marketing Company Name
Pharmavic Iberica S.L.
Authorization Date
2023-07-10
Dosage Form
SOLUCIÓN INYECTABLE
Dose
20 mg/ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Seacross Pharma (Europe) Limited
Active Ingredients
PLERIXAFOR
20 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 10, 2023
Approval ID
780f2665726ca292
Type
Standard
Back to CIMA-AEMPS Approvals
